Drug-resistant TB treatment: concerns over absconding patients

dc.date.accessioned	2015-09-25	en
dc.date.accessioned	2022-08-17T16:19:41Z
dc.date.available	2022-08-17T16:19:41Z
dc.date.issued	2015-09-25	en
dc.identifier.uri	http://www.hsrc.ac.za/en/review/hsrc-review-july-to-sept-2015/drug-resistant-tb-treatment	en
dc.identifier.uri	http://hdl.handle.net/20.500.11910/1797
dc.description.abstract	A study in Khayelitsha in the Western Cape illustrated the difficulty of retaining patients on drug-resistant TB treatment, a tendency that poses a significant threat to containing the spread of multidrug-resistant TB in the country, writes Sizulu Moyo. That drug-resistant TB is increasing year-on-year is clear when analysing the number of multidrug-resistant TB cases.	en
dc.format.medium	Intranet	en
dc.subject	TUBERCULOSIS	en
dc.subject	TREATMENT CENTRES	en
dc.subject	KHAYELITSHA	en
dc.subject	CAPE TOWN	en
dc.title	Drug-resistant TB treatment: concerns over absconding patients	en
dc.type	Journal Article	en
dc.description.version	N	en
dc.ProjectNumber	N/A	en
dc.Volume	13(3)	en
dc.BudgetYear	2015/16	en
dc.ResearchGroup	HIV/AIDS, STIs and TB	en
dc.SourceTitle	HSRC Review	en
dc.ArchiveNumber	8806	en
dc.URL	http://ktree.hsrc.ac.za/doc_read_all.php?docid=25340	en
dc.PageNumber	21-23	en
dc.outputnumber	7558	en
dc.bibliographictitle	Moyo, S. (2015) Drug-resistant TB treatment: concerns over absconding patients. HSRC Review. 13(3):21-23. http://hdl.handle.net/20.500.11910/1797	en
dc.publicationyear	2015	en
dc.contributor.author1	Moyo, S.	en